Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06539013

Efficacy of Remifentanil in Preventing Emergence Agitation

Efficacy of Remifentanil in Preventing Emergence Agitation in Patients Undergoing Nasal Surgery Under Desflurane Anesthesia: A Prospective Double-blind Randomized Controlled Trial.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
99 (estimated)
Sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The primary aim of the study was to test the hypothesis that remifentanil administered for analgesia prevents emergence agitation more effectively than fentanyl and N2O in patients undergoing rhinoplasty who received desflurane as an inhaled anesthetic agent. The secondary aim of the study was to compare the demographic data, intraoperative and postoperative hemodynamic data, surgical time and modified Aldrete score of patients who received different intraoperative analgesia methods.

Conditions

Interventions

TypeNameDescription
DRUGRemifentanilremifentanil infusion
DRUGN2OUse of N2O for analgesia
DRUGFentanylUse of Fentanylfor analgesia

Timeline

Start date
2024-08-01
Primary completion
2024-09-30
Completion
2024-10-01
First posted
2024-08-06
Last updated
2024-08-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06539013. Inclusion in this directory is not an endorsement.